Jennifer Smith, MS, RD, CSP, LD, LMT, Nationwide Children's Hospital
                 Learning objectives:

• Define ARFID and briefly review current literature including and gaps in knowledge in AFRID in pediatric IBD
• Describe study methods including benefits and limitations of screening tools
• Present most recent data for this single-center study

9:15 AM Nutritional Strategies for Avoidant Restrictive Food Intake Disorder: A Dietitian’s Approach
                Shawna Jenkins, MS, RD, LDN, Orlando Health
                Learning objectives:

• Learners will be able to define ARFID, and will be able to differentiate between ARFID and pediatric feeding disorder
• Learners will be able to identify ways dietitians can support families during ARFID treatment
• Discuss effects of multidisciplinary interventions on managing disorder

10:00 - 10:30 AM  Break in Exhibit Hall

10:30 AM - 12:00 PM CPNP Session II
10:30 AM Wild Animals I Have Known: Alpha-Gal Syndrome, the Three C’s, and other Tangential Tales
                  Barrett  Barnes, MD, University of Virginia
                   Learning objectives:

• Define the unique delayed IgE-mediated food allergy syndrome Alpha-Gal Syndrome (AGS)
• Review the evolving understanding of the pathophysiology
• Review the current diagnostic evaluation
• Review current therapy strategies

11:15 AM Bad to the Bone: Improving Pediatric Bone Health 
                  Tamara Sims-Dorway, RD, CSP, LD/N, Arnold Palmer Hospital Pediatric Center for
                  Digestive Health and Nutrition
                  Learning objectives:

• Review steps taken to create a multidisciplinary Pediatric GI bone clinic
• Describe the criteria and clinical measures used to assess bone health in pediatric patients
• Discuss effects of multidisciplinary interventions on bone health as evidenced by DEXA scan results and surgical feedback/assessments
• Compare and contrast application of nutrition interventions in varying disease states

12:00 PM – 2:00 PM Poster Session III/Lunch in Exhibit Hall

2:00 PM - 3:30 PM  NASPGHAN Concurrent Session V
What's in a Name? MASLD and Obesity
Moderators: Ulrich Baumann, MD, ESPGHAN President, Medizinische Hochschule Hannover

2:00 PM Unraveling MASLD: New Nomenclature, Definitions and the Impact of Malnutrition in Pediatric MASLD
               Mohit Kehar, MD, Children's Hospital of Eastern Ontario
               Learning objectives:

• Understand the New Nomenclature and Definitions
• Recognize the New Diagnostic Criteria
• Understand the Key Relationship Between Malnutrition (Undernutrition/Overnutrition) and MAFLD

2:25 PM Abstract
2:37 PM Staying off Medications: Nutritional Treatment of MASLD and Obesity
                Sara Karjoo, MD, CPE, FOMA, Johns Hopkins Hospital
                Learning objectives:

• Compare and contrast the evidence-based diets for treatment of MASLD and Obesity in children
• Recognize which diets improve MASLD and/or provide weight loss

3:02 PM CBT/Psychological Aspects of Behavioral Changes, Multiple Markers of Success:
              Interdisciplinary Treatment of MASLD and Obesity
              E Thomaseo Burton, PhD, MPH, ABPP, Children's Hospital of Philadelphia and 
              Venus Setareh Kalami, MNSP, RD, CSP, Lucile Packard Stanford Children's Health
              Learning objectives:

• Discuss the roles of nutrition and psychology in addressing eating behaviors, lifestyle habits, and body image
• Review psychological techniques (e.g., motivational interviewing, cognitive behavioral therapy) that support adherence to treatment recommendations
• Explore reframing patient and provider goals toward non-weight outcomes

3:45 PM - 4:30 PM CPNP Session III
                Optimizing Nutrition for Pediatric Liver Transplant Patients
                Elizabeth  Scott, RD, CNSC, CSP, Children's Hospital Los Angeles
                Learning objectives:

• Discuss the role of the dietitian through the phases of the transplant process
• Identify appropriate markers of nutrition in pediatric liver disease
• Identify common barriers that advancing liver disease present to providing adequate nutrition
• Describe strategies to address manifestations of end stage liver disease that may interfere with optimizing nutrition

               Baby-Led Weaning in 3D
               Tatiana Maldonado, MS, CCC-SLP, CLEC, Children's Hospital Los Angeles and
               Christy Gardner Figueredo, MS, RD, LD/N, University of Miami
               Learning objectives:

• Define baby-led weaning (BLW)
• List components of the BLW approach to feeding and benefits of early exposure to a variety of foods and nutrient needs
• Identify safe presentations of a variety of foods from ages 6mo-24 mo
• Incorporate BLW to various cultural and socioeconomic needs
• Counsel on appropriate BLW and common parental concerns